Use Of High- And Low-Value Health Care Among US Adults, By Income, 2010-19.
Park, Sungchul, and Rishi K Wadhera. 2024. “Use Of High- And Low-Value Health Care Among US Adults, By Income, 2010-19.”. Health Affairs (Project Hope) 43 (7): 1021-31.
Search
Search results
2980 results found
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.
Sims, Kendra D, Pengxiao Carol Wei, Joanne M Penko, Susan Hennessy, Pamela G Coxson, Nita H Mukand, Brandon K Bellows, et al. 2024. “Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.”. Hypertension (Dallas, Tex. : 1979) 81 (8): 1758-65.
The March Toward Improved Heart Failure Outcomes Requires an Emphasis on Affordability.
Foote, Julia H A, and Dhruv S Kazi. 2024. “The March Toward Improved Heart Failure Outcomes Requires An Emphasis on Affordability.”. JACC. Heart Failure 12 (7): 1238-41.
Catheter-associated urinary tract infection (CAUTI) reduction in a neuroscience intensive care unit: A multidisciplinary approach.
McGloin, Jamie M, Patrick Gordon, Baevin Feeser, Joanna Anderson, Suzanne Joyner, Jacqueline Bentick, Anna Morien, Corey R Fehnel, Michael N Cocchi, and Dana E Pepe. 2024. “Catheter-Associated Urinary Tract Infection (CAUTI) Reduction in a Neuroscience Intensive Care Unit: A Multidisciplinary Approach.”. American Journal of Infection Control 52 (3): 368-70.
Insights Derived from the Synthesis of a Complex Core 2 Glycan.
Dhakal, Bibek, Appi Mandhapati, Simon Park, Lijun Sun, and Elliot L Chaikof. 2024. “Insights Derived from the Synthesis of a Complex Core 2 Glycan.”. The Journal of Organic Chemistry 89 (16): 11641-58.
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
Koerner, Steffi K, Jun-Ichi Hanai, Sha Bai, Finith E Jernigan, Miwa Oki, Chieko Komaba, Emi Shuto, Vikas P Sukhatme, and Lijun Sun. 2017. “Design and Synthesis of Emodin Derivatives As Novel Inhibitors of ATP-Citrate Lyase.”. European Journal of Medicinal Chemistry 126: 920-28.
Novel indolyl-chalcones target stathmin to induce cancer cell death.
Wegiel, Barbara, Yiqiang Wang, Mailin Li, Finith Jernigan, and Lijun Sun. 2016. “Novel Indolyl-Chalcones Target Stathmin to Induce Cancer Cell Death.”. Cell Cycle (Georgetown, Tex.) 15 (9): 1288-94.
Synthesis, crystallographic characterization and electrochemical property of a copper(II) complex of the anticancer agent elesclomol.
Vo, Nha Huu, Zhiqiang Xia, Jason Hanko, Tong Yun, Steve Bloom, Jianhua Shen, Keizo Koya, Lijun Sun, and Shoujun Chen. 2014. “Synthesis, Crystallographic Characterization and Electrochemical Property of a Copper(II) Complex of the Anticancer Agent Elesclomol.”. Journal of Inorganic Biochemistry 130: 69-73.
Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines.
James, David A, Keizo Koya, Hao Li, Guiqing Liang, Zhiqiang Xia, Weiwen Ying, Yaming Wu, and Lijun Sun. 2008. “Indole- and Indolizine-Glyoxylamides Displaying Cytotoxicity Against Multidrug Resistant Cancer Cell Lines.”. Bioorganic & Medicinal Chemistry Letters 18 (6): 1784-7.
Associations of stem cell markers CD44, CD24 and ALDH1A1 with mammographic breast density in women with benign breast biopsies.
Yaghjyan, Lusine, Yujing J Heng, Gabrielle M Baker, Divya Murthy, Matt B Mahoney, Bernard Rosner, and Rulla M Tamimi. 2024. “Associations of Stem Cell Markers CD44, CD24 and ALDH1A1 With Mammographic Breast Density in Women With Benign Breast Biopsies.”. Br J Cancer 131 (2): 325-33.